CN117701617A - Method for improving kojic acid yield and application - Google Patents
Method for improving kojic acid yield and application Download PDFInfo
- Publication number
- CN117701617A CN117701617A CN202311661954.2A CN202311661954A CN117701617A CN 117701617 A CN117701617 A CN 117701617A CN 202311661954 A CN202311661954 A CN 202311661954A CN 117701617 A CN117701617 A CN 117701617A
- Authority
- CN
- China
- Prior art keywords
- kojic acid
- koja
- protein
- gene
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 title claims abstract description 98
- 229960004705 kojic acid Drugs 0.000 title claims abstract description 98
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 title claims abstract description 98
- 238000000034 method Methods 0.000 title claims abstract description 51
- 241000894006 Bacteria Species 0.000 claims abstract description 37
- 101150072858 kojA gene Proteins 0.000 claims abstract description 33
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 33
- 241000228245 Aspergillus niger Species 0.000 claims abstract description 28
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 27
- 238000000855 fermentation Methods 0.000 claims abstract description 26
- 230000004151 fermentation Effects 0.000 claims abstract description 26
- 101150112266 vgb gene Proteins 0.000 claims abstract description 19
- 239000013612 plasmid Substances 0.000 claims description 21
- 239000002609 medium Substances 0.000 claims description 18
- 239000002773 nucleotide Substances 0.000 claims description 17
- 125000003729 nucleotide group Chemical group 0.000 claims description 17
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 claims description 15
- 238000003208 gene overexpression Methods 0.000 claims description 14
- 230000002018 overexpression Effects 0.000 claims description 14
- 241000589158 Agrobacterium Species 0.000 claims description 13
- 239000001965 potato dextrose agar Substances 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000003550 marker Substances 0.000 claims description 12
- 101100234558 Aspergillus oryzae (strain ATCC 42149 / RIB 40) kojA gene Proteins 0.000 claims description 11
- 239000001963 growth medium Substances 0.000 claims description 11
- 230000001404 mediated effect Effects 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 229940041514 candida albicans extract Drugs 0.000 claims description 5
- 239000012138 yeast extract Substances 0.000 claims description 5
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 claims description 4
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 claims description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 4
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 239000008223 sterile water Substances 0.000 claims description 4
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- 238000012262 fermentative production Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 238000010353 genetic engineering Methods 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- 239000002207 metabolite Substances 0.000 abstract description 2
- 238000010369 molecular cloning Methods 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 14
- 230000014509 gene expression Effects 0.000 description 12
- 239000013613 expression plasmid Substances 0.000 description 8
- 238000012795 verification Methods 0.000 description 8
- 240000006439 Aspergillus oryzae Species 0.000 description 6
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 6
- 238000010276 construction Methods 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 101150020820 vhb gene Proteins 0.000 description 6
- 238000005215 recombination Methods 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 241000351920 Aspergillus nidulans Species 0.000 description 4
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 4
- 229940097277 hygromycin b Drugs 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 3
- 229960004261 cefotaxime Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 102100021979 Asporin Human genes 0.000 description 1
- 101100184662 Caenorhabditis elegans mogs-1 gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 101000752724 Homo sapiens Asporin Proteins 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007376 cm-medium Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/99—Other carbon-oxygen lyases (4.2.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/66—Aspergillus
- C12R2001/685—Aspergillus niger
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of bioengineering, and discloses a method for improving the yield of kojic acid, which is realized by utilizing aspergillus niger engineering bacteria of a kojic acid-producing strain, wherein the method simultaneously overexpresses a plurality of copy numbers of KojA proteins and VHb proteins in the aspergillus niger strain; kojic acid producing strain Aspergillus niger engineering bacteria which over express KojA protein and VHb protein can produce kojic acid in fermentation, and the yield of kojic acid reaches 40g/L to 100g/L. The kojA gene is over-expressed in the aspergillus niger and copied into the strain by a molecular cloning technology and a genetic engineering technology, and the exogenous gene vgb gene which can improve the growth of the strain, promote the synthesis of protein and improve the yield of metabolites can be over-expressed on the basis. Finally, the recombinant strain can produce kojic acid with high yield. Finally, the kojic acid yield of the recombinant strain can reach 40-100 g/L. The invention can be used for the industrial production of kojic acid.
Description
Technical Field
The invention belongs to the technical field of bioengineering, and particularly relates to a method for improving the yield of kojic acid and application thereof.
Background
Kojic acid is an important industrial raw material, and can be used as a preservative, an oxidant for fats and oils, and an antibacterial agent in foods and pesticides. The cosmetic industry can be used as skin brightening agent and ultraviolet protecting agent in soap, facial cream, etc., and has effects of whitening skin and resisting aging. In the production and preparation of chemicals, metal adsorbents are used as binders between metals and organic materials. The pharmaceutical aspect is antifungal medicine or component as effective bactericide. At present, kojic acid is mainly produced by fermenting Aspergillus oryzae, but the fermentation strain of Aspergillus oryzae adopted at present and the fermentation performance thereof are difficult to further improve and optimize, the yield is generally maintained at about 30g/L, and the yield of glucose serving as a substrate is not more than 0.3g/g. With the increasing demands of various industries for kojic acid, there is a more urgent need for cheaper, convenient and low-cost kojic acid production methods. The engineering strain for obtaining the high-yield kojic acid by adopting biological engineering, metabolic engineering and synthetic biological methods is a potential direction.
Given that the biosynthesis pathway of kojic acid is not resolved, there are few reports of achieving heterologous synthesis of kojic acid in other strains incapable of naturally synthesizing kojic acid.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provides a method for improving the yield of kojic acid and application thereof.
The technical scheme adopted for solving the technical problems is as follows:
a method for increasing kojic acid production by using a kojic acid producing strain, the method over-expressing a KojA protein and a VHb protein in the kojic acid producing strain; the kojic acid producing engineering strain which over-expresses the KojA protein and the VHb protein can produce kojic acid in fermentation, and the kojic acid yield reaches 40g/L to 100g/L.
Further, the kojic acid producing strain is aspergillus nidulans and aspergillus niger.
Further, the method of overexpressing the KojA protein is that the copy number of the gene kojA encoding the KojA protein in the engineering strain is 2 to 5.
Further, the method for realizing the overexpression of the KojA protein and the overexpression of the kojA genes with the copy number of 2 to 5 is specifically as follows: the kojA gene overexpression plasmid pLH1081 is obtained by artificially synthesizing a kojA gene nucleotide sequence and connecting the kojA gene nucleotide sequence to a plasmid pLH 454; and transferring pLH1081 into a kojic acid-producing strain by using an agrobacterium-mediated method to obtain a kojA gene over-expression engineering bacterium, then after losing a hygromycin resistance screening marker hph in the engineering bacterium, transferring the engineering bacterium into a kojic acid-producing strain engineering bacterium in which a next round of agrobacterium-mediated pLH1081 is lost and the hygromycin resistance screening marker hph is obtained in the last round, and thus obtaining the kojic acid-producing strain kojic acid-producing engineering bacterium in which the KojA protein over-expression and the copy number of 2 to 5 kojA genes are over-expressed through 2 to 5 rounds of circulation.
Further, the nucleotide sequence of the kojA gene is SEQ NO.1, and the amino acid sequence of the KojA protein is SEQ NO.2.
Further, the method for over-expressing the VHb protein comprises the following steps: the nucleotide sequence of the vgb gene is artificially synthesized and connected to a plasmid pLH454 to obtain a vgb gene overexpression plasmid pLH1261; and transferring the pLH1261 into kojic acid producing strain engineering bacteria capable of producing kojic acid by using an agrobacterium-mediated method, so as to realize the over-expression of VHb protein in Aspergillus niger engineering bacteria capable of producing kojic acid.
Further, the nucleotide sequence of the vgb is SEQ NO.3, and the amino acid sequence of the VHb protein is SEQ NO.4.
Use of a method as described above for increasing the yield of kojic acid.
A method for fermentative production of kojic acid using the method as described above comprising the steps of:
obtaining kojic acid producing strain Aspergillus niger engineering bacteria which over express KojA protein and VHb proteinInoculating the obtained kojic acid-producing engineering bacteria into a potato dextrose agar culture medium for 5 days; then adding sterile water, and washing out spores by using a cotton swab; the number of spores in the spore liquid was counted by using a hemocytometer at 5X 10 7 Inoculating the spores/mL into a fermentation culture medium, and culturing in a shaking table at 28 ℃ for 5-7 days at 100-300 rpm;
wherein, the formula of the fermentation medium is as follows: 0.1 to 3.5g/L of yeast extract, 0.1 to 2g/L of monopotassium phosphate, 0.1 to 1g/L of magnesium sulfate heptahydrate, 0.1 to 200g/L of glucose and 0.1 to 1.5mol/L of MES morpholinoethanesulfonic acid, and the pH value is regulated to 6.5 by using sodium hydroxide solid.
The invention has the advantages and positive effects that:
1. the invention constructs a series of new kojic acid production engineering strains by adopting a new method, the obtained aspergillus nidulans and aspergillus niger engineering bacteria can be applied to the kojic acid biological fermentation production, the obtained strains are fermented for 3-7 days under the shake flask condition, the kojic acid yield is 40-90g/L, and the glucose is used as a substrate, the yield is more than 0.7g/g, compared with the yield and the yield of the aspergillus oryzae strains commonly used in industry, the yield of kojic acid produced by the microbial fermentation method is greatly improved, and the invention provides new excellent strains and an optimization technology for improving the yield of kojic acid produced by the microbial fermentation method. The invention has obvious innovation and provides a new technology for the field of kojic acid biosynthesis.
2. The invention over-expresses the reported gene kojA gene for key kojic acid production in aspergillus flavus in aspergillus niger and copies the gene into a strain by a molecular cloning technology and a genetic engineering technology, and on the basis, the over-expression can improve the growth of the strain, promote the protein synthesis and improve the exogenous gene VHb gene of metabolite yield. Finally, the recombinant strain can produce kojic acid with high yield. Finally, the kojic acid yield of the recombinant strain can reach 40-100 g/L. The invention can be used for producing kojic acid from Aspergillus niger and Aspergillus nidulans in industry.
Drawings
FIG. 1 is a map of a starting plasmid pLH454 in the present invention;
FIG. 2 is a map of a kojA gene expression plasmid pLH1081 constructed in the present invention;
FIG. 3 is a map of the VHb gene expression plasmid pLH1261 constructed in the present invention;
FIG. 4 is a diagram showing the digestion verification of the kojA gene expression plasmid pLH1081 and the VHb gene expression plasmid pLH1261 according to the present invention; wherein M is DNA Marker,1, 2 are single restriction enzyme verification diagrams of kojA gene expression plasmid pLH1081 and VHb gene expression plasmid pLH1261; 3. 4 is a VHb gene expression plasmid pLH1261 double restriction enzyme verification graph (NcoI, speI, 7530bp/2887 bp); 5. 6 is a single restriction map (EcoRI, 8814bp/2464 bp) of the kojA gene expression plasmid pLH1081;
FIG. 5 shows the kojic acid yield after shaking flask fermentation for 5 days of fermentation broth supernatant after 2-5 copies of kojA gene and overexpression of vgb gene are introduced into the strain;
Detailed Description
The invention will now be further illustrated by reference to the following examples, which are intended to be illustrative, not limiting, and are not intended to limit the scope of the invention.
The various experimental operations involved in the specific embodiments are conventional in the art, and are not specifically noted herein, and may be implemented by those skilled in the art with reference to various general specifications, technical literature or related specifications, manuals, etc. before the filing date of the present invention.
A method for increasing kojic acid production by using a kojic acid producing strain, the method over-expressing a KojA protein and a VHb protein in the kojic acid producing strain; the kojic acid producing engineering strain which over-expresses the KojA protein and the VHb protein can produce kojic acid in fermentation, and the kojic acid yield reaches 40g/L to 100g/L.
Preferably, the kojic acid producing strain is Aspergillus nidulans and Aspergillus niger.
Preferably, the method for over-expressing the KojA protein is that the copy number of the gene kojA encoding the KojA protein in the engineering strain is 2 to 5.
Preferably, the method for realizing the overexpression of the KojA protein and the overexpression of the kojA genes with the copy number of 2 to 5 is specifically as follows: the kojA gene overexpression plasmid pLH1081 is obtained by artificially synthesizing a kojA gene nucleotide sequence and connecting the kojA gene nucleotide sequence to a plasmid pLH 454; and transferring pLH1081 into a kojic acid-producing strain by using an agrobacterium-mediated method to obtain a kojA gene over-expression engineering bacterium, then after losing a hygromycin resistance screening marker hph in the engineering bacterium, transferring the engineering bacterium into a kojic acid-producing strain engineering bacterium in which a next round of agrobacterium-mediated pLH1081 is lost and the hygromycin resistance screening marker hph is obtained in the last round, and thus obtaining the kojic acid-producing strain kojic acid-producing engineering bacterium in which the KojA protein over-expression and the copy number of 2 to 5 kojA genes are over-expressed through 2 to 5 rounds of circulation.
Preferably, the nucleotide sequence of the kojA gene is SEQ NO.1, and the amino acid sequence of the KojA protein is SEQ NO.2.
Preferably, the method for over-expressing the VHb protein comprises the following steps: the nucleotide sequence of the vgb gene is artificially synthesized and connected to a plasmid pLH454 to obtain a vgb gene overexpression plasmid pLH1261; and transferring the pLH1261 into kojic acid producing strain engineering bacteria capable of producing kojic acid by using an agrobacterium-mediated method, so as to realize the over-expression of VHb protein in Aspergillus niger engineering bacteria capable of producing kojic acid.
Preferably, the nucleotide sequence of the vgb is SEQ NO.3, and the amino acid sequence of the VHb protein is SEQ NO.4.
Use of a method as described above for increasing the yield of kojic acid.
A method for fermentative production of kojic acid using the method as described above comprising the steps of:
obtaining kojic acid producing strain Aspergillus niger engineering bacteria which over express KojA protein and VHb protein, inoculating the obtained kojic acid producing engineering bacteria into potato dextrose agar culture medium for 5 days; then adding sterile water, and washing out spores by using a cotton swab; the number of spores in the spore liquid was counted by using a hemocytometer at 5X 10 7 Inoculating the spores/mL into a fermentation culture medium, and culturing in a shaking table at 28 ℃ for 5-7 days at 100-300 rpm;
wherein, the formula of the fermentation medium is as follows: 0.1 to 3.5g/L of yeast extract, 0.1 to 2g/L of monopotassium phosphate, 0.1 to 1g/L of magnesium sulfate heptahydrate, 0.1 to 200g/L of glucose and 0.1 to 1.5mol/L of MES morpholinoethanesulfonic acid, and the pH value is regulated to 6.5 by using sodium hydroxide solid.
Specifically, the preparation and detection of the correlation are as follows:
example 1: construction of kojA Gene overexpression plasmid pLH1081
The kojA gene used in the experiment is a gene fragment artificially synthesized after codon optimization. PCR amplification is carried out by adopting primers Primer3650 and Primer3651, ecoRI and SacI are subjected to double digestion and glue recovery, then the PCR amplification is carried out, the PCR amplification is connected with a vector pLH454 (shown in figure 1) obtained by treating with the same restriction enzyme by means of a One Step Clone Kit kit, the connected product is physically and chemically transferred into E.coli JM109 competent cells, the E.coli JM109 competent cells are evenly coated in LB solid medium containing 100 mug/mL kanamycin resistance, the culture is carried out after inversion overnight at 37 ℃, a monoclonal is selected, and the pLH1081 is obtained through colony PCR verification and plasmid double digestion verification, the map of the plasmid double digestion verification is shown in figure 2.
Example 2: construction of the vgb Gene overexpression plasmid pLH1261
The vgb gene used in the experiment is a gene fragment artificially synthesized after codon optimization. PCR amplification was performed using primers P454-vhb R and P454-vhb L, ecoRI and SacI were digested and gel recovered, and then ligated with the vector pLH454 (FIG. 1) obtained by the same restriction enzyme treatment by means of One Step Clone Kit kit, the ligation product was chemically transferred to E.coli JM109 competent cells, uniformly spread on LB solid medium containing 100. Mu.g/mL kanamycin resistance, cultured overnight at 37℃in an inverted state, and single clones were picked up and subjected to colony PCR and plasmid double digestion verification to obtain pLH1261, the map of which is shown in FIG. 3, and plasmid double digestion verification is shown in FIG. 4.
Table 1 primer sequences used in the examples
Example 3: construction of Gene expression Strain: taking construction of a kojA expression Strain as an example, construction of a kojA Gene-overexpressing Strain
Agrobacterium containing plasmid pLH1081 was co-cultured with spores of A.niger host strain S469 (see for details Engineering aPhosphoketolase Pathway to Supplement Cytosolic Acetyl-CoA in Aspergillus niger Enables aSignificant Increase in Citric Acid Production, J Fungi (Basel). 2023Apr 23;9 (5): 504.Doi:10.3390/jof 9050504) on IM plates, and the co-culture was then transferred to CM plates containing 200. Mu.M cefotaxime, 100. Mu.g/mL ampicillin, 100. Mu.g/mL streptomycin, 250. Mu.g/mL hygromycin B, and incubated at 28℃until a monoclonal was formed. Selecting a monoclonal and transferring the monoclonal to a potato dextrose agar culture medium plate containing hygromycin B (250 mug/mL) and a potato dextrose agar culture medium plate, extracting genome from a transformant, verifying to obtain a hygromycin-resistant expression strain containing a kojA gene, selecting one of correct clones to carry out resistance marker hygromycin induced recombination so as to obtain a single copy kojA gene overexpression strain S3145 without hygromycin resistance. The second copy of the kojA gene was overexpressed using S3145 as starting strain, thus until a copy number of 2-5 was reached.
The electrotransformation conditions of the agrobacterium-mediated method are as follows: capacitence 25uF, voltage 2.5kV,
Resistance:200Ω,Pulse:5msec。
the Agrobacterium strain used is an AGL-1 strain.
The preparation method of the IM culture medium comprises the following steps: 15g agar is added with water to a volume of 905.7mL, sterilized for 20min at 121 ℃, and added with sterile KBuffer 0.8mL, MN buffer 20mL, 1% CaCl2.2H2O 1mL, 0.01% FeSO410mL, IM Trace elements mL and 20% NH which are prepared in advance 4 NO 3 2.5 mL, 50% glycerol 10mL, 1M MES 40mL, 20% glucose 5mL, kanamycin was added to a final concentration of 100. Mu.g/mL and acetosyringone was added to a final concentration of 200. Mu.M when the temperature was cooled to about 50 ℃.
The preparation method of the CM culture medium comprises the following steps: adding water into 20g agar to volume of 897mL, sterilizing at 121deg.C for 20min, adding 20mL sterile ASPN solution (KCl 26.1g/L, KH) 2 PO 4 74.8 g/L,NaNO 3 297.5 g/L, pH adjusted to 5.5), 20mL of 50% glucose, 2mL of 1M MgSO 4 1, mL CM Trace elements (component per 100)The mL contains ZnSO 4 ·7H 2 O 2.1g,H 3 BO 3 1.1g,MnCl 2 ·4H 2 O 0.5g,FeSO 4 ·7H 2 O 0.5g,CoCl 2 ·6H2O 0.17g,CuSO 4 ·5H 2 O 0.16g,Na 2 MoO 4 ·2H 2 O0.15 g, EDTA 5.1 g), 10mL 10% casein hydrolysate, 50mL 10% yeast extract, hygromycin was added to a final concentration of 250. Mu.g/mL, streptomycin to a final concentration of 100. Mu.g/mL, cefotaxime to a final concentration of 100. Mu.g/mL, ampicillin to a final concentration of 100. Mu.g/mL when the temperature was cooled to about 50 ℃.
The resistance marker induction recombination method comprises the following steps: spores of about 300 kojA gene-expressing clones were uniformly spread on MM medium containing 15mg/mL xylose, cultured at 28℃until single clones were grown, 200 single clones were randomly selected and transferred onto potato dextrose agar medium at 28℃for 24 hours, then clones were transferred onto potato dextrose agar medium containing hygromycin (250. Mu.g/mL) in one-to-one correspondence for 24 hours, and finally transformants were phenotypically selected for resistance marker-induced recombination, i.e., transformants which could not normally grow on potato dextrose agar medium containing hygromycin for successful induction of recombination.
The preparation method of the potato dextrose agar medium comprises the following steps: accurately weighing 500g of peeled potato, cutting into about 1cm 3 Adding distilled water, continuously stirring, boiling for 30min, filtering with double-layer gauze, collecting filtrate, adding 50g glucose, stirring to dissolve completely, metering distilled water to 2.5L, packaging in wide-mouth bottles, adding 1.5% agar, and sterilizing at 121deg.C under high pressure for 20min.
Example 4: the engineering strain simultaneously expressing the vgb and the multicopy kojA is constructed by over-expressing the vgb gene on the basis of the engineering strain expressing the kojA gene
Agrobacterium containing plasmid pLH1261 was co-cultured with the 2-5 copy kojA gene expressing Aspergillus niger spores obtained in the construction of example 3 on IM plates, and the co-culture was transferred to CM plates containing 200. Mu.M cefotaxime, 100. Mu.g/mL ampicillin, 100. Mu.g/mL streptomycin, 250. Mu.g/mL hygromycin B and cultured at 28℃until a monoclonal was formed. Selecting a monoclonal and transferring the monoclonal to a potato dextrose agar medium plate containing hygromycin B (250 mug/mL) and a potato dextrose agar medium plate, extracting genome from a transformant, verifying to obtain a hygromycin-resistant expression strain containing the vgb gene, selecting one of the correct clones to carry out resistance marker hygromycin induced recombination, thereby obtaining the Aspergillus niger engineering bacterium which does not have hygromycin resistance, over-expresses 2-5 copies of the kojA gene and over-expresses the vgb.
Example 5: application of engineering strain in fermentation to produce kojic acid
The method for producing kojic acid by fermenting the Aspergillus niger kojic acid production engineering bacteria in a shake flask, which is constructed by the invention, comprises the following specific steps:
fermentation medium: 0.1 to 3.5g/L of yeast extract, 0.1 to 2g/L of monopotassium phosphate, 0.1 to 1g/L of magnesium sulfate heptahydrate, 0.1 to 200g/L of glucose and 0.1 to 1.5mol/L of MES morpholinoethanesulfonic acid, and the pH value is regulated to 6.5 by using sodium hydroxide solid.
The fermentation method comprises the following steps: inoculating Aspergillus niger kojic acid production engineering bacteria into potato dextrose agar medium for culturing for 5 days. Then, a proper amount of sterile water was added and spores were washed off with a cotton swab. The number of spores in the spore liquid was counted by using a hemocytometer at 5X 10 7 The individual spores/mL are inoculated in a fermentation culture medium and are cultured in a shaking table, wherein the culture condition is 28 ℃, the rotation speed is 100-300 rpm, and the time period is 5-7 days.
The preparation method of the detection sample comprises the following steps:
1mL of the bacterial liquid was collected in a shake flask fermented for 5 days, and the supernatant was collected by centrifugation at 12000rpm for 5 min. The supernatant was aspirated into a 1.5mL EP tube, diluted 10-fold with ultrapure water, and the sample was filtered using a 1mL syringe with a fluid 13mm0.22um filter.
The method for detecting the organic acid by the high performance liquid chromatography comprises the following steps: agilent high performance liquid chromatograph UV detector, aminexHPX 87H column (300 mM 7.8 mM), 5mM H 2 SO 4 Mobile phase, flow rate of 0.6mL/min, chromatographic column temperature of 65 ℃, detection wavelength of 210nm, 20 mu L sample injectionVolume.
The LB medium, potato dextrose agar medium, IM medium, CM medium, MM medium, and the like are the same as those described in publication Sun Jing and the like in the establishment of an Aspergillus niger genetic transformation system in which amdS is a selection marker (Sun Jing, et al, chinese agricultural science and technology, guide, 2020,22 (09): 179-187).
And finally, collecting fermentation products, preparing a detection sample, and measuring the content of kojic acid in the sample through high performance liquid chromatography. The results are shown in FIG. 5. As shown in FIG. 5, after 7 days of shake flask fermentation, the koji acid yield of the koji acid production engineering bacteria constructed by the invention gradually increases along with the increase of the copy number of the over-expressed koiA gene, and the koji acid final concentrations of the koiA gene over-expressed engineering bacteria with the single copy, double copy, triple copy, four copy and five copy numbers respectively reach 10g/L,25g/L,30g/L,33g/L and 36g/L. Wherein, the two Aspergillus niger engineering bacteria are obtained by further over-expressing the vgb genes on the basis of the three-copy number and five-copy number koiA gene over-expression engineering bacteria, and the final concentration of the kojic acid reaches 45g/L and 60g/L after 7 days of shake flask fermentation.
The invention provides a genetic engineering modification method for effectively improving the yield of kojic acid. The kojic acid yield of the kojic acid production strain Aspergillus oryzae commonly used in the industry at present is about 30g/L, and the kojic acid engineering strain constructed by the invention is greatly higher than the kojic acid production strain Aspergillus oryzae in terms of yield. The invention realizes the efficient synthesis of kojic acid in heterologous host Aspergillus niger, and the developed Aspergillus niger engineering strain and corresponding fermentation process are different from the existing Aspergillus oryzae kojic acid producing strain and related fermentation process, and has new technical characteristics, thus providing a new technical scheme for the efficient industrial production of kojic acid.
SEQ NO.1: nucleotide sequence 1281bp of KojA gene
CGTGTCGCGACACAGCTAAGGGTCGGCATCGTCGGTGGCGGATGGAACGGCTGCCATCTTGCTTTAGAGCTCAAGAAACAGGGCCACCGAGTTTCTTTGTTCGAGCAGAAGCCTGATATCTTTCAAGGCGTCTCAGGAAACTTTGGTATCCGCTTGCACAAGGGGCCACACTACCCTCGGTCTAAAGCAACTCGAGACAGCTGCCGTGAAGCCTTGGTCAAGTTCTGTGAGACGTATCCCGAACTAGTCGTCCACCATGAATCCGCGATATATGCACACGGCGAAGCGGACGCTCTGGGGAACCCATCGAAGGTCTCGGATGAGGCATTCAGGGATGTATGCTACGAATCTCCTGAGTGTACTGCGGTTGATCCGAAGGCGAATGGTTTCCAGGGCCTCATCAGCGCATACAATCTGGATGAACCCAGCGTCGCTATTGGCGACCGACTCCGGAATACATTCAAAGAGAAACTTGGTCGTGCAGGCATCTACGTGCACCTCAATGCAACAGTCGACCGTATCATCCACACCGAGGACACCAACCGCATTCAAACCGGGGACGGGCAGTACGTCTTTGACGTAGTGATCAACGCCACCGGTTATACCAGCCTTCTGCCACAAAATATTGCAGATGCTCTTCCGGTTGACATTGGCATCACCTATCAGACCTGTATTGCTCTCGTTTACGAAGACCAGCAGCCACAGGAAAAGCCTCTTTCCTTCATTGTCATGGATGGCTGGTTTCCCTGCGTGATGCCGGCGATCGACACAAACGAGCCCCTTCAGAAGAAGTATATCTTGACACACGGCAGTTACACCATCCTCGGATCATTCGACCGTCACGAGGAGGGTCAAGAGCTTCTGGATAGTCTGGACGAGGAAGCTATCGCTGCTCGGATCAAGCCCCACTGTGAGCGGGAGATTACCCGGTTCTGGCCCGGATTTCTCGATCGGTTCCAGTACCGCGGCTGGAAGGGCAGTGTCCTGGCCAAGTTAAAGACCACATCCGAATTCCGAAGCAGTTTGACGTTTGAAAAAGACGGCGTGATCCACATCTTCCCCGGCAAGGTGAGCAACGTTGTAACGGCTGCCGAGGAAGTGGTTCCTCTGATCAATGACATTGCGCGCCGACGGCACGGTGTGGTTCGGGAGTGGAATGGCGTACGCTTCACTGTGAGCAGCGCCTTCCACACCCACAGCAAGGAGATTGGCGATAAGCCAGGGCTGGGCGAGCACCACACTAGCAACTTGCAGACCTATGTTTCACTAGTGACTGCAAAC
SEQ NO.2: amino acid sequence 427aa of the kojA gene
RVATQLRVGIVGGGWNGCHLALELKKQGHRVSLFEQKPDIFQGVSGNFGIRLHKGPHYPRSKATRDSCREALVKFCETYPELVVHHESAIYAHGEADALGNPSKVSDEAFRDVCYESPECTAVDPKANGFQGLISAYNLDEPSVAIGDRLRNTFKEKLGRAGIYVHLNATVDRIIHTEDTNRIQTGDGQYVFDVVINATGYTSLLPQNIADALPVDIGITYQTCIALVYEDQQPQEKPLSFIVMDGWFPCVMPAIDTNEPLQKKYILTHGSYTILGSFDRHEEGQELLDSLDEEAIAARIKPHCEREITRFWPGFLDRFQYRGWKGSVLAKLKTTSEFRSSLTFEKDGVIHIFPGKVSNVVTAAEEVVPLINDIARRRHGVVREWNGVRFTVSSAFHTHSKEIGDKPGLGEHHTSNLQTYVSLVTANSEQ NO.3: nucleotide sequence 441bp of vgb gene
ATGCTGGATCAGCAGACCATCAACATCATCAAGGCCACCGTCCCCGTCCTGAAGGAGCACGGTGTCACTATTACCACCACCTTCTACAAGAACCTGTTCGCCAAGCACCCCGAGGTCCGCCCTTTGTTTGATATGGGCCGCCAGGAGTCCCTGGAGCAGCCTAAAGCTCTGGCTATGACCGTCCTGGCTGCTGCTCAAAATATCGAGAACCTGCCCGCTATTCTGCCCGCCGTCAAAAAGATCGCCGTCAAGCACTGCCAGGCCGGCGTTGCCGCTGCTCATTATCCTATTGTCGGTCAGGAGCTGCTGGGCGCCATTAAGGAAGTCCTGGGCGATGCCGCCACCGATGATATCCTGGATGCCTGGGGCAAGGCCTACGGCGTTATTGCCGATGTCTTTATCCAGGTCGAGGCCGATCTGTACGCCCAGGCCGTTGAATAA
SEQ NO.4: amino acid sequence 146aa of the VHb gene
MLDQQTINIIKATVPVLKEHGVTITTTFYKNLFAKHPEVRPLFDMGRQESLEQPKALAMTVLAAAQNIENLPAILPAVKKIAVKHCQAGVAAAHYPIVGQELLGAIKEVLGDAATDDILDAWGKAYGVIADVFIQVEADLYAQAVE
Although embodiments of the present invention have been disclosed for illustrative purposes, those skilled in the art will appreciate that: various substitutions, changes and modifications are possible without departing from the spirit and scope of the invention and the appended claims, and therefore the scope of the invention is not limited to the disclosure of the embodiments.
Claims (9)
1. A method for increasing kojic acid yield, characterized by: the method utilizes a kojic acid producing strain to realize the improvement of kojic acid yield, and the method over-expresses KojA protein and VHb protein in the kojic acid producing strain; the kojic acid producing engineering strain which over-expresses the KojA protein and the VHb protein can produce kojic acid in fermentation, and the kojic acid yield reaches 40g/L to 100g/L.
2. The method according to claim 1, characterized in that: the kojic acid producing strain is Aspergillus niger.
3. The method according to claim 1, characterized in that: the method for over-expressing the KojA protein is that the copy number of the gene kojA encoding the KojA protein in the engineering strain is 2 to 5.
4. A method according to claim 3, characterized in that: the method for realizing the overexpression of the KojA protein and the overexpression of the kojA genes with the copy number of 2 to 5 comprises the following specific steps: the kojA gene overexpression plasmid pLH1081 is obtained by artificially synthesizing a kojA gene nucleotide sequence and connecting the kojA gene nucleotide sequence to a plasmid pLH 454; and transferring pLH1081 into a kojic acid-producing strain by using an agrobacterium-mediated method to obtain a kojA gene over-expression engineering bacterium, then after losing a hygromycin resistance screening marker hph in the engineering bacterium, transferring the engineering bacterium into a kojic acid-producing strain engineering bacterium in which a next round of agrobacterium-mediated pLH1081 is lost and the hygromycin resistance screening marker hph is obtained in the last round, and thus obtaining the kojic acid-producing strain Aspergillus niger engineering bacterium in which the KojA protein over-expression and the copy number of the kojA gene over-expression are 2 to 5 through 2 to 5 rounds of circulation.
5. The method according to claim 1, characterized in that: the nucleotide sequence of the kojA gene is SEQ NO.1, and the amino acid sequence of the KojA protein is SEQ NO.2.
6. The method according to any one of claims 1 to 5, wherein: the method for over-expressing the VHb protein comprises the following steps: the nucleotide sequence of the vgb gene is artificially synthesized and connected to a plasmid pLH454 to obtain a vgb gene overexpression plasmid pLH1261; and transferring the pLH1261 into Aspergillus niger engineering bacteria capable of producing kojic acid by using an agrobacterium-mediated method, so as to realize the over-expression of VHb protein in the Aspergillus niger engineering bacteria for producing kojic acid.
7. The method according to claim 6, wherein: the nucleotide sequence of the vgb is SEQ NO.3, and the amino acid sequence of the VHb protein is SEQ NO.4.
8. Use of the method according to any one of claims 1 to 7 for increasing the yield of kojic acid.
9. A process for the fermentative production of kojic acid using the process according to any one of claims 1 to 7, characterized in that: the method comprises the following steps:
obtaining kojic acid producing strain Aspergillus niger engineering bacteria which over express KojA protein and VHb protein, inoculating the obtained kojic acid producing engineering bacteria into potato dextrose agar culture medium for 5 days; then adding sterile water, and washing out spores by using a cotton swab; the number of spores in the spore liquid was counted by using a hemocytometer at 5X 10 7 Inoculating the spores/mL into a fermentation culture medium, and culturing in a shaking table at 28 ℃ for 5-7 days at 100-300 rpm;
wherein, the formula of the fermentation medium is as follows: 0.1 to 3.5g/L of yeast extract, 0.1 to 2g/L of monopotassium phosphate, 0.1 to 1g/L of magnesium sulfate heptahydrate, 0.1 to 200g/L of glucose and 0.1 to 1.5mol/L of MES morpholinoethanesulfonic acid, and the pH value is regulated to 6.5 by using sodium hydroxide solid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311661954.2A CN117701617A (en) | 2023-12-06 | 2023-12-06 | Method for improving kojic acid yield and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311661954.2A CN117701617A (en) | 2023-12-06 | 2023-12-06 | Method for improving kojic acid yield and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117701617A true CN117701617A (en) | 2024-03-15 |
Family
ID=90147140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311661954.2A Pending CN117701617A (en) | 2023-12-06 | 2023-12-06 | Method for improving kojic acid yield and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117701617A (en) |
-
2023
- 2023-12-06 CN CN202311661954.2A patent/CN117701617A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2990071C (en) | Production of cannabigerolic acid | |
CN112195110B (en) | Recombinant aspergillus oryzae strain and kojic acid fermentation method and application thereof | |
CN113604472B (en) | CRISPR/Cas gene editing system applied to Trichoderma reesei | |
CN111662831A (en) | Aspergillus niger Rha-N1 and application thereof | |
CN112175849A (en) | Recombinant yeast with improved L-menthol yield | |
CN113846024B (en) | Method for reducing byproduct fumaric acid in L-malic acid fermentation process, strain and application | |
CN113249287B (en) | Bacillus subtilis engineering strain for expressing D-psicose 3-epimerase and application thereof | |
CN109486688B (en) | Trichoderma reesei genetic engineering bacterium and preparation method and application thereof | |
CN111088175A (en) | Yarrowia lipolytica for producing bisabolene and construction method and application thereof | |
CN106032525A (en) | A genetically engineered bacterium for synthesizing resveratrol and a constructing method thereof | |
CN117701617A (en) | Method for improving kojic acid yield and application | |
WO2023115997A1 (en) | Recombinant corynebacterium glutamicum for producing isomaltulose, and application thereof | |
CN116262903A (en) | Aspergillus oryzae engineering bacteria, construction method and application | |
CN112920959B (en) | Method for increasing yield of L-menthol in saccharomycetes | |
CN116024109B (en) | Rhodosporidium toruloides engineering strain for high-yield nervonic acid and construction method and application thereof | |
CN114806899B (en) | Trichoderma reesei engineering bacteria for producing L-malic acid and application thereof | |
LU102870B1 (en) | Recombinant corynebacterium strain for modifying 5'-end sequence of 4-hydroxy-tetrahydrodipicolinate synthase (hts) gene and use thereof | |
CN114958853B (en) | Low-sugar response inducible promoter derived from aspergillus niger, method and application thereof | |
CN117025421A (en) | Recombinant strain for producing abscisic acid and construction method and application thereof | |
CN118222411A (en) | Aspergillus niger strain for producing organic acid, method and application | |
CN118256407A (en) | Engineering bacterium for catalytic synthesis of 1, 5-pentanediamine by using L-lysine as substrate, construction method and application | |
CN105985987B (en) | biological method for preparing fatty alcohol | |
CN116240118A (en) | Recombinant strain for improving organic acid production level and fermentation strength, construction method and application thereof | |
CN114606146A (en) | Yeast for producing D-limonene and application thereof | |
CN115976075A (en) | Method for heterologously synthesizing taxadiene by utilizing chlamydomonas reinhardtii chloroplast and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |